サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1663438

AIベースのデジタルパソロジー市場：ニューラルネットワーク別、コンポーネント別、用途別、最終用途別、国別、地域別 - 世界産業分析、市場規模、市場シェア、予測（2025年～2032年）

AI-based Digital Pathology Market, By Neural Network, By Component, By Application, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 381 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
AIベースのデジタルパソロジー市場：ニューラルネットワーク別、コンポーネント別、用途別、最終用途別、国別、地域別 - 世界産業分析、市場規模、市場シェア、予測（2025年～2032年）
出版日: 2025年01月04日
発行: AnalystView Market Insights
ページ情報: 英文 381 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

AIベースのデジタルパソロジー市場規模は2024年に8,560万米ドルで、2025年から2032年にかけて15.80%のCAGRで拡大

AIベースのデジタルパソロジー市場-市場力学

個別化医療への需要の高まり

AIベースのデジタルパソロジー市場は、個別化された投薬に対する需要の高まりにより、今後拡大すると予測されます。患者一人ひとりのニーズ、選好、特徴に合わせて医療や治療をカスタマイズすることは、個別化医療として知られています。個別化医療は、各患者固有の遺伝子プロファイル、ライフスタイルの選択、病気の特徴に合わせて治療法をカスタマイズすることで、有効性を向上させ、副作用を減少させるために必要性が高まっています。遺伝子データや医療画像をより正確かつ効率的に解析できるようになることで、AIを活用したデジタルパソロジーは、より正確な診断、疾患サブタイプの特定、各患者特有の生物学的プロファイルに合わせた治療レジメンのカスタマイズを容易にし、個別化医療をサポートします。例えば、米国を拠点とする専門家会員組織Personalized Medicine Coalitionが2023年2月に発表した報告書によると、2022年には12の新しい個別化治療薬が承認され、これは全新治療薬のおよそ34%に相当し、それ以前に比べて顕著な増加を示しています。このように、AIベースのデジタルパソロジー市場は、オーダーメイド治療への需要の高まりにより拡大しています。

AIベースのデジタルパソロジー市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025年～2032年）に約15.80％のCAGRで毎年成長すると推定されます。

ニューラルネットワークのセグメンテーションに基づくと、畳み込みニューラルネットワーク（CNN）が2024年に最大市場シェアを示すと予測されました。

用途別では、創薬が2024年の主要セグメントでした。

最終用途セグメンテーションに基づくと、2024年には病院とリファレンスラボが主要セグメントでした。

地域別では、アジア太平洋が2024年の売上高をリードしました。

AIベースのデジタルパソロジー市場-セグメンテーション分析：

世界のAIベースのデジタルパソロジー市場は、ニューラルネットワーク、コンポーネント、用途、最終用途、地域に基づいてセグメント化されます。

コンポーネントベースでは、市場はスキャナとソフトウェアに分別されます。2024年には、市場はソフトウェアカテゴリによって支配されました。これは、デジタルパソロジーにおける人工知能ソフトウェアの使用が増加しているためであり、病理医の時間、精度、結果のスピードが低下し、医師が患者の健康状態を評価し、回復薬を迅速にスケジュールできるようになったことがその要因です。さらに、AIは患者の健康データの保存と結果の検索に効果的に使用される可能性があり、調査期間中にAIベースのデジタルパソロジーソフトウェアの需要が増加します。

最終用途に基づき、市場は病院・基準研究所、製薬・バイオテクノロジー企業、学術・研究機関に分けられます。2024年には、病院・基準検査室カテゴリーが圧倒的な市場シェアを占めています。病院と基準検査室は、おそらく日々増加する病理学関連の症例に対処することになると思われます。病理検査の仕事の負担が増えることで、信頼性の高い結果を出す能力と時間節約能力により、AIの利用が必要になります。加えて、病院はAIのおかげで、より多くの症例を管理するために必要な病理医の数を減らすことができます。これにより、世界のAIベースのデジタルパソロジー市場が今後数年間で成長するための新たな道がさらに開かれることになります。

AIベースのデジタルパソロジー市場-地理的洞察

2024年には、アジア太平洋がAIベースのデジタルパソロジー診断の世界市場で支配的な地位を占めました。AIベースのデジタルパソロジー市場は、中国やインドのような新興国におけるヘルスケア分野でのAIの適用拡大により拡大しています。NASSCOMによると、2025年までにインドのヘルスケアAI市場はCAGR40％で拡大すると予測されています。これは、医療分野におけるAIの利用が拡大していることを示しており、反復作業を迅速に完了し、病理医の時間を節約できることから、病理学への応用が促進される可能性があります。人工知能は病理医関連業務の一部をこなすことができるため、この分野における下級病理医の存在がヘルスケア開業医の利用を後押しし、調査期間中の需要を高めています。

しかし、予測期間を通じて、北米地域は遠隔医療の利用が拡大しているため、CAGRが最も速いと予測されています。COVID-19は、厳格な監禁要件のため、対面セッションの代わりに遠隔医療の使用を奨励しました。米国保健社会福祉省によると、米国のメディケア受給者は、流行以来、遠隔医療を頻繁に利用しています。米国では、2019年の11億件から、2020年には9億8,900万件の対面診療がありました。遠隔診療の予約件数は、2019年の840万件から2020年には5,270万件近くに増加しました。取引コストの減少により増加が予想されるこの動向の進展に伴い、医師による遠隔診療を支援するAIベースの技術が求められます。

AIベースのデジタルパソロジー市場-競合情勢：

DoMore Diagnostics AS、Aiforia Technologies、Aiosyn、Deep Bio、F. Hoffmann-La Rocheなど、AIベースのデジタルパソロジー市場の主要企業は、患者の転帰を向上させ、プロセスを迅速化し、診断精度を高めるために、高度ながん検出機器などの最先端製品の創出に注力しています。AIを搭載した高度ながん検出ツールは、ディープラーニングモデルと機械学習アルゴリズムを使用して病理スライドと医療画像を評価し、腫瘍の識別と分類の精度を向上させます。例えば、2022年2月、Crosscope Inc.とMindPeak GmbHは、MindPeakの画像解析ツールをCrosscopeのDigital Pathologyプラットフォームに組み込むことで提携しました。クロスコープのAI能力はこの提携によって向上し、完全なデジタルパソロジーソリューションを提供できるようになりました。最先端のAIツールの円滑な統合を通じて、この協業は病理組織学のワークフローを合理化し、病理医がラボの生産性を向上させ、ER、PR、Ki-67 IHC分析で迅速かつ重要な診断を提供できるよう支援することを目指しています。統合の結果、患者の治療成績が向上することが期待されます。

最近の開発動向

2024年1月：Rocheは、米国カリフォルニア州バークレーを拠点とする非上場企業Carmot Therapeutics, Inc. ("Carmot")を買収する合併契約を最終決定したと発表しました。Carmotの研究開発ポートフォリオには、糖尿病の有無にかかわらず、肥満症の治療薬としてクラス最高の可能性を持つ前臨床試験や臨床段階の経口・皮下インクレチンが含まれます。

2023年10月：クラウドサービスプロバイダーのAmazon Web Services, Inc.の協力を得て、F. Hoffmann-La Roche Ltd.とIbex Medical Analytics Ltd.は、AIを活用したがん検出ソリューションを提供するために提携しました。この提携は、Navify Digital Pathologyソフトウェアプラットフォームを通じて、病理検査室にアイベックスのAI駆動型意思決定支援機能へのアクセスを提供するものです。臨床医はこの統合を通じて前立腺がんや乳がんの診断支援を受けることができます。

2023年9月：欧州、カナダ、アジア太平洋市場において、Hologic, Inc.とBayer AGは、より良い乳がん発見のための造影マンモグラフィ（CEM）ソリューションを提供するために提携しました。BayerとHologicの技術を組み合わせることで、マンモグラフィ検査時の造影剤塗布をより容易にすることを期待しています。この提携は、放射線技師に完全な製品バンドル、実践的な指導、スムーズなCEMワークフローの統合を提供することに重点を置いています。

2023年6月：米国を拠点とするデジタルパソロジーおよび計算病理学ソリューションのサプライヤーであるProscia Inc.は、MindPeak GmbHと提携しました。この提携は、AIを活用したワークフローを緊密に連携させることで、病理医がより効果的で、知識が豊富で、再現性のある臨床結論に到達できるよう支援することを目指すものです。その目的は、がん患者がより良い診断を受けられるようにすることです。

目次

第1章 AIベースのデジタルパソロジー市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 AIベースのデジタルパソロジーの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 AIベースのデジタルパソロジー産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 AIベースのデジタルパソロジー市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 AIベースのデジタルパソロジー市場情勢

  • AIベースのデジタルパソロジー市場シェア分析、2024年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 AIベースのデジタルパソロジー市場-ニューラルネットワーク別

  • 概要
    • ニューラルネットワークによるセグメントシェア分析
    • 生成的敵対ネットワーク（GANS）
    • リカレントニューラルネットワーク（RNN）
    • 畳み込みニューラルネットワーク（CNN）
    • その他

第8章 AIベースのデジタルパソロジー市場-コンポーネント別

  • 概要
    • セグメントシェア分析：コンポーネント別
    • スキャナー
    • ソフトウェア

第9章 AIベースのデジタルパソロジー市場-用途別

  • 概要
    • セグメントシェア分析：用途別
    • 創薬
    • 臨床ワークフロー
    • トレーニング・教育
    • 病気の診断と予後

第10章 AIベースのデジタルパソロジー市場-最終用途別

  • 概要
    • セグメントシェア分析：最終用途別
    • 病院・検査機関
    • 製薬・バイオテクノロジー企業
    • 学術・研究機関

第11章 AIベースのデジタルパソロジー市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-AIベースのデジタルパソロジー業界

  • 競合ダッシュボード
  • 企業プロファイル
    • DoMore Diagnostics AS
    • Aiforia Technologies
    • Aiosyn
    • Deep Bio
    • F. Hoffmann-La Roche
    • Akoya Biosciences
    • deepPath
    • Hologic
    • Konfoong Biotech International
    • Koninklijke Philips NV
    • 4D Path
    • Lumea
    • Ibex Medical Analytics
    • Indica Labs
    • Mindpeak
    • その他

第13章 アナリストの全方位展望

目次
Product Code: ANV4620

REPORT HIGHLIGHT

AI-based Digital Pathology Market size was valued at US$ 85.6 Million in 2024, expanding at a CAGR of 15.80% from 2025 to 2032.

AI-based digital pathology is a cutting-edge method of using digital technologies and artificial intelligence to diagnose and analyze illnesses. In order to identify patterns, anomalies, and particular disease signs, pathology slides are digitized into high-resolution images and subsequently sent to AI algorithms for analysis. By automating repetitive procedures, increasing diagnostic precision, and spotting minute details that would be overlooked during manual inspection, these AI systems might help pathologists. The AI-based digital pathology market is growing as a result of the growing emphasis on hospital cost control and efficiency enhancement, the rising need for technologically sophisticated solutions, and the rising number of incorrect diagnoses. Additionally, it is anticipated that government-funded research initiatives that support the creation of cutting-edge digital tools for pathology would support the AI-based digital pathology market growth.

AI-based Digital Pathology Market- Market Dynamics

Growing demand for personalized medication

The market for AI-based digital pathology is anticipated to increase in the future due to the growing demand for personalized medication. Customizing medical care and treatment to each patient's unique needs, preferences, and traits is known as personalized medicine. Personalized medicine is becoming more and more necessary in order to improve efficacy and decrease side effects by customizing therapies to each patient's unique genetic profile, lifestyle choices, and illness features. By making it possible to analyze genetic data and medical images more accurately and efficiently, AI-based digital pathology supports personalized medicine by facilitating more precise diagnosis, improved identification of disease subtypes, and customized treatment regimens that fit each patient's particular biological profile. For instance, a report released in February 2023 by the US-based professional membership organization Personalized Medicine Coalition stated that the approval of 12 new personalized medications in 2022-roughly 34% of all new therapies-represented a notable increase over prior years. Thus, the market for AI-based digital pathology is expanding due to the growing demand for tailored therapy.

AI-based Digital Pathology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.80% over the forecast period (2025-2032)

Based on neural network segmentation, the convolutional neural networks (CNNs) were predicted to show maximum market share in the year 2024

Based on application segmentation, drug discovery was the leading segment in 2024

Based on end use segmentation, hospitals & reference laboratories were the leading segment in 2024

On the basis of region, Asia-Pacific was the leading revenue generator in 2024

AI-based Digital Pathology Market- Segmentation Analysis:

The Global AI-based Digital Pathology Market is segmented on the basis of Neural Network, Component, Application, End Use, and Region.

On the basis of component, the market is segregated into Scanners and Software. In 2024, the market was dominated by the software category due to the increasing use of artificial intelligence software in digital pathology, which has been fueled by a decrease in pathologists' time, accuracy, and speed of results, enabling physicians to assess a patient's health and schedule recovery medication rapidly. Additionally, AI may be used effectively to store patient health data and retrieve results, which will increase the demand for AI-based digital pathology software during the study period.

Based on end use, the market is divided into Hospitals & Reference Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. In 2024, the hospitals & reference laboratories category held a dominant market share. Hospitals and reference labs will probably deal with an increasing number of pathology-related cases every day. The increasing burden for pathology jobs will need the use of AI due to its ability to produce reliable results and its time-saving capabilities. Additionally, hospitals can reduce the number of pathologists they require to manage more cases thanks to AI. This will further open up new avenues for the global AI-based digital pathology market to grow in the years to come.

AI-based Digital Pathology Market- Geographical Insights

In 2024, Asia-Pacific held a dominant position in the global market for AI-based Digital Pathology. The market for AI-based digital pathology is expanding due to the expanding application of AI in healthcare sectors in developing nations like China and India. By 2025, the healthcare AI market in India is anticipated to expand at a 40% CAGR, according to NASSCOM. This illustrates the growing usage of AI in the medical field, which could encourage its application in pathology due to its speedy completion of repetitive tasks and capacity to save pathologists time. Because artificial intelligence can do some pathologist-related duties, the presence of lower-level pathologists in the area is pushing healthcare practitioners to use it, increasing demand for it during the research period.

However, throughout the projected period, the North America region is anticipated to see the fastest CAGR because of the growing use of telemedicine. Due to strict lockdown requirements, COVID-19 encouraged the use of telemedicine instead of in-person sessions. Medicare beneficiaries in the US have been using telemedicine more frequently since the epidemic, according to the US Department of Health and Human Services. In the United States, there were 989 million in-person medical visits in 2020, up from 1.1 billion in 2019. By 2020, there were almost 52.7 million telemedicine appointments, up from 8,40,000 in 2019. AI-based technologies that assist physicians in treating patients remotely will be required as this trend, which is anticipated to increase due to decreased transaction costs, develops.

AI-based Digital Pathology Market- Competitive Landscape:

Leading players in the AI-based digital pathology market, such as DoMore Diagnostics AS, Aiforia Technologies, Aiosyn, Deep Bio, F. Hoffmann-La Roche, and others, are concentrating on creating cutting-edge products, such as sophisticated cancer detection instruments to boost patient outcomes, expedite processes, and increase diagnostic precision. AI-powered advanced cancer detection tools use deep learning models and machine learning algorithms to evaluate pathology slides and medical images, improving the precision of tumour identification and classification. For instance, in February 2022, Crosscope Inc. and MindPeak GmbH partnered to include MindPeak's image analysis tools into Crosscope's Digital Pathology platform. Crosscope's AI capabilities are improved by this collaboration, allowing them to offer complete digital pathology solutions. Through the smooth integration of cutting-edge AI tools, the collaboration seeks to streamline Histopathology workflows, assisting pathologists in enhancing lab productivity and providing prompt and significant diagnoses for ER, PR, and Ki-67 IHC analysis. Treatment outcomes for patients are expected to improve as a result of the integration.

Recent Development

January 2024: Roche declared that it had finalized a merger deal to buy Berkeley, California-based Carmot Therapeutics, Inc. ("Carmot"), a privately held US business. Carmot's research and development portfolio includes a range of preclinical studies and clinically staged oral and subcutaneous incretins with best-in-class potential to treat obesity in individuals with and without diabetes.

October 2023: With the help of cloud service provider Amazon Web Services, Inc., F. Hoffmann-La Roche Ltd. and Ibex Medical Analytics Ltd. have partnered to offer AI-powered cancer detection solutions. Through the Navify Digital Pathology software platform, this partnership seeks to provide pathology labs with access to Ibex's AI-driven decision support capabilities. Clinicians can get help diagnosing prostate and breast cancer through this integration.

September 2023: In the European, Canadian, and Asia Pacific markets, Hologic, Inc. and Bayer AG have teamed together to offer contrast-enhanced mammography (CEM) solutions for better breast cancer detection. By combining Bayer and Hologic's technology, the alliance hopes to make it easier to apply contrast media during mammography exams. The collaboration is centred on offering radiologists complete product bundles, practical instruction, and smooth CEM workflow integration.

June 2023: Proscia Inc., a U.S.-based supplier of digital and computational pathology solutions, has partnered with MindPeak GmbH. Through closely coordinated AI-powered workflows, this collaboration seeks to assist pathologists in reaching more effective, knowledgeable, and repeatable clinical conclusions. The objective is to increase cancer patients' access to better diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • DoMore Diagnostics AS
  • Aiforia Technologies
  • Aiosyn
  • Deep Bio
  • F. Hoffmann-La Roche
  • Akoya Biosciences
  • deepPath
  • Hologic
  • Konfoong Biotech International
  • Koninklijke Philips N.V.
  • 4D Path
  • Lumea
  • Ibex Medical Analytics
  • Indica Labs
  • Mindpeak
  • Others

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY NEURAL NETWORK- MARKET ANALYSIS, 2019 - 2032

  • Generative adversarial networks (GANS)
  • Recurrent neural networks (RNNs)
  • Convolutional neural networks (CNNs)
  • Others

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Scanners
  • Software

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery
  • Clinical Workflow
  • Training & Education
  • Disease Diagnosis & Prognosis

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Reference Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI-based Digital Pathology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI-based Digital Pathology Market Snippet by Neural Network
    • 2.1.2. AI-based Digital Pathology Market Snippet by Component
    • 2.1.3. AI-based Digital Pathology Market Snippet by Application
    • 2.1.4. AI-based Digital Pathology Market Snippet by End Use
    • 2.1.5. AI-based Digital Pathology Market Snippet by Country
    • 2.1.6. AI-based Digital Pathology Market Snippet by Region
  • 2.2. Competitive Insights

3. AI-based Digital Pathology Key Market Trends

  • 3.1. AI-based Digital Pathology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI-based Digital Pathology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI-based Digital Pathology Market Opportunities
  • 3.4. AI-based Digital Pathology Market Future Trends

4. AI-based Digital Pathology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI-based Digital Pathology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI-based Digital Pathology Market Landscape

  • 6.1. AI-based Digital Pathology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI-based Digital Pathology Market - By Neural Network

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Neural Network, 2024 & 2032 (%)
    • 7.1.2. Generative adversarial networks (GANS)
    • 7.1.3. Recurrent neural networks (RNNs)
    • 7.1.4. Convolutional neural networks (CNNs)
    • 7.1.5. Others

8. AI-based Digital Pathology Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 8.1.2. Scanners
    • 8.1.3. Software

9. AI-based Digital Pathology Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery
    • 9.1.3. Clinical Workflow
    • 9.1.4. Training & Education
    • 9.1.5. Disease Diagnosis & Prognosis

10. AI-based Digital Pathology Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Reference Laboratories
    • 10.1.3. Pharmaceutical & Biotechnology Companies
    • 10.1.4. Academic & Research Institutes

11. AI-based Digital Pathology Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. AI-based Digital Pathology Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. AI-based Digital Pathology Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. France
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. France Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.9.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. Italy
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. Italy Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.10.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Spain
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. United Kingdom
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. United Kingdom Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.12.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. Russia
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Russia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Netherlands
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Netherlands Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Sweden
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Sweden Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.2. Poland Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. AI-based Digital Pathology Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. South Korea
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. South Korea Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. Japan
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. Japan Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.11.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. AI-based Digital Pathology Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. AI-based Digital Pathology Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- AI-based Digital Pathology Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. DoMore Diagnostics AS
    • 12.2.2. Aiforia Technologies
    • 12.2.3. Aiosyn
    • 12.2.4. Deep Bio
    • 12.2.5. F. Hoffmann-La Roche
    • 12.2.6. Akoya Biosciences
    • 12.2.7. deepPath
    • 12.2.8. Hologic
    • 12.2.9. Konfoong Biotech International
    • 12.2.10. Koninklijke Philips N.V.
    • 12.2.11. 4D Path
    • 12.2.12. Lumea
    • 12.2.13. Ibex Medical Analytics
    • 12.2.14. Indica Labs
    • 12.2.15. Mindpeak
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us